Dalton Transactions · 2011 · 108 citations · 67 references
MedicineOncologyPharmacologyRadiobiologyRadionuclide TherapyTherapeutic Nuclear MedicineAlpha-particle TherapyParticle TherapyRadiopharmaceuticalsTargeted Cancer TherapyTargeted Radionuclide TherapyTargeted TherapyAlpha-emitting RadiopharmaceuticalsBeta-emitting RadionuclidesBeta-emitting RadiopharmaceuticalsHigh-linear Energy Transfer Radiation EffectsLinear Energy Transfer EffectsPhysical PropertiesRadionuclide FateTargeted Radiopharmaceutical Therapy
Targeted α‑particle therapy, with its short path length and high linear energy transfer, offers precise tumor cell killing and has shown promise in pre‑targeted approaches using α‑emitters such as (212)Bi and its longer‑lived parent (212)Pb, which has been effective in radioimmunotherapy and in combination with chemotherapeutics. This perspective aims to evaluate the use of (212)Pb in targeted and pre‑targeted radiation therapy. It discusses radionuclide production, radiolabelling, chelation chemistry, and application strategies for (212)Pb.
Targeted α-particle therapy offers the potential for more specific tumor cell killing with less damage to surrounding normal tissue than β-emitters because of the combination of short path length (50-80 μm) with the high linear energy transfer (100 keV μm(-1)) of this emission. These physical properties offer the real possibility of targeted (pre-targeted) α-therapy suitable for the elimination of minimal residual or micrometastatic disease. Targeted and pre-targeted radioimmunotherapy (RIT) using α-emitters such as (212)Bi (T(1/2) = 1.01 h) and (212)Pb (T(1/2) = 10.6 h) has demonstrated significant utility in both in vitro and in vivo model systems. (212)Pb, a promising α-particle emitting source, is the longer-lived parent nuclide of (212)Bi, and serves as an in vivo generator of (212)Bi. The radionuclide has been successfully used in RIT and pre-targeted RIT and demonstrated an enhanced therapeutic efficacy in combination with chemotherapeutics, such as gemcitabine and paclitaxel. The following perspective addresses the modes of radionuclide production, radiolabelling and chelation chemistry, as well as the application of (212)Pb to targeted and pre-targeted radiation therapy.
67
Metal complexes of cyclic tetra-azatetra-acetic acids
Rita Delgado, João J. R. Fraústo da Silva · Talanta · 1982 · 167 citations